Company intelligence / Profile preview
ASLAN Pharmaceuticals
Singapore, Central, Singaporeaslanpharma.com ↗
- Ownership
- Public · ASLN
- Employees
- ~38
- Development stage
- Other
01
Overview
ASLAN Pharmaceuticals was a clinical-stage immunology-focused biopharmaceutical company. Its lead asset eblasakimab showed positive topline data in a Phase 2b study for moderate-to-severe atopic dermatitis in biologic-naïve patients. Farudodstat was being evaluated as an oral treatment for alopecia areata with interim readout expected mid-2024. The company previously completed a Phase II/III trial of varlitinib in gastric cancer but has since focused on immunology and dermatology indications. In July 2024, the company announced voluntary liquidation of its sole operating subsidiary due to financial difficulties[1][7][10].
- Therapeutic areas
- OncologyImmunologyDermatology
- Modalities
- Monoclonal antibodies (mAbs)Small molecules
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Zenyaku Kogyo Co., Ltd.: research collaboration for development/commercialization of eblasakimab in Japan[4].Thermo Fisher Scientific Inc.: manufacturing partnership for high concentration formulation of eblasakimab for late-stage trials[6].
Beyond the preview
Go deeper on ASLAN Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ASLAN Pharmaceuticals.